<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05111132</url>
  </required_header>
  <id_info>
    <org_study_id>P2021/055/CCB B4062021000019</org_study_id>
    <nct_id>NCT05111132</nct_id>
  </id_info>
  <brief_title>Can Peripheral NIRS Predict the Response to a Fluid Challenge in Pediatric Patients: An Interventional Study</brief_title>
  <official_title>Can Peripheral NIRS Predict the Response to a Fluid Challenge in Pediatric Patients: An Interventional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted on pediatric patients up to 14 years of age. The effect of two&#xD;
      fluid challenge regimes on cerebral and peripheral NIRS will be assessed, in a randomized&#xD;
      double blinded controlled trial. The findings will be correlated with two ultrasound&#xD;
      measures, previously validated as markers of fluid responsiveness.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 29, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of fluid challenge on NIRS (peripheral/cerebral)</measure>
    <time_frame>peri-operative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>7.5 ml/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1, receiving a fluid challenge of 7,5 ml/kg in 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12.5 ml/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2, 12.5 ml/kg of fluid challenge in 5 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fluid challenge (cristallo√Ød, NaCl 0,9%)</intervention_name>
    <description>A fluid challenge according to group will be administrated by infusion pump</description>
    <arm_group_label>12.5 ml/kg</arm_group_label>
    <arm_group_label>7.5 ml/kg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all operations excepting cardiac surgery&#xD;
&#xD;
          -  BMI &lt; 30&#xD;
&#xD;
          -  ages 1-14 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any cardiac affection (congenital unoperated heart disease, arrythmias)&#xD;
&#xD;
          -  icterus&#xD;
&#xD;
          -  refusal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre Pandin, MD</last_name>
    <phone>+3225555812</phone>
    <email>Pierre.Pandin@erasme.ulb.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Erasmus Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Pandin, MD</last_name>
      <phone>+3225555812</phone>
      <email>pierre.pandin@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Lulia Scolobiuc</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

